Financial Instruments Measured at Fair Value (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2022:

(thousands)	Balance Sheet Location	Level 1		Level 2		Level 3		Total
Cash equivalents (a)	Cash and cash equivalents/ Other assets	$	6,596	$	—	$	—	$	6,596
Equity investments (b)	Other assets	50,614		—		—		50,614
Interest rate swaps designated as cash flow hedges	Other assets	—		55,942		—		55,942
Foreign exchange contracts designated as net investment hedges	Other assets	—		60,962		—		60,962
		$	57,210	$	116,904	$	—	$	174,114

The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2021:

(thousands)	Balance Sheet Location	Level 1		Level 2		Level 3		Total
Cash equivalents (a)	Cash and cash equivalents/ Other assets	$	4,812	$	—	$	—	$	4,812
Equity investments (b)	Other assets	56,985		—		—		56,985
Interest rate swaps designated as cash flow hedges	Other assets	—		21,831		—		21,831
Foreign exchange contracts designated as net investment hedges	Other assets	—		40,612		—		40,612
		$	61,797	$	62,443	$	—	$	124,240

(a)    Cash equivalents include highly liquid investments with an original maturity of less than three months.

(b)    The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. During 2022, 2021, and 2020 the company recorded unrealized gains (losses) of $(5.8) million, $7.8 million, and $(0.2) million, respectively, on equity securities held at the end of each year.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]

The effects of derivative instruments on the company’s consolidated statements of operations and other comprehensive income are as follows for the years ended December 31:

(thousands)	Income Statement Line	2022		2021		2020
Gain (Loss) Recognized in Income (Loss)
Foreign exchange contracts, net investment hedge (a)	Interest Expense	$	8,805	$	8,805	$	8,805
Interest rate swaps, cash flow hedge	Interest Expense	(3,586)		(3,087)		(3,979)
Total		$	5,219	$	5,718	$	4,826
Gain (Loss) Recognized in Other Comprehensive Income (Loss) before reclassifications, net of tax
Foreign exchange contracts, net investment hedge (b)		$	15,474	$	21,133	$	(6,802)
Interest rate swaps, cash flow hedge		25,937		19,232		(12,023)
Total		$	41,411	$	40,365	$	(18,825)

(a)Represents derivative amounts excluded from the assessment of effectiveness for the net investment hedges reclassified from CTA to Interest and other financing expenses, net.

(b)Includes derivative gains (losses) excluded from the assessment of effectiveness for the net investment hedges and recognized in other comprehensive income (net of tax) of $1.8 million, $(0.6) million, and $18.0 million for 2022, 2021, and 2020, respectively.

Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]

Fair Value Disclosures

Description of Types of Hedging Instruments Used

At December 31, 2022 and 2021, the company had the following outstanding interest rate swaps designated as cash flow hedges:

Trade Date	Maturity Date	Notional Amount  (thousands)	Weighted-Average Interest Rate	Date Range of Forecasted Transaction
April 2020	December 2024	$300,000	0.97%	Jan 2023 - Dec 2025

Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]

Fair Value Disclosures

Description of Types of Hedging Instruments Used

Maturity Date	Notional Amount  (thousands)
March 2023	EUR	50,000
September 2024	EUR	50,000
April 2025	EUR	100,000
January 2028	EUR	100,000
Total	EUR	300,000